Find clinical trials for Ovarian Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Rochester, MN, USA:
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The st...
Phase 3
Rochester, Minnesota, United States and 5 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Rochester, Minnesota, United States and 176 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Rochester, Minnesota, United States and 41 other locations
study drugs pembrolizumab and lenvatinib in patients with clear cell ovarian cancer.The names of the study drugs involved in this s...
Phase 2
Rochester, Minnesota, United States and 2 other locations
This phase II trial studies how well pembrolizumab works in treating participants with ovarian cancer that has come back after prev...
Phase 2
Rochester, Minnesota, United States and 2 other locations
of ubamatamab can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study wil...
Phase 1, Phase 2
Rochester, Minnesota, United States and 53 other locations
, which are pieces of a protein known as "folate receptor alpha" (FRalpha), a protein that is found in high levels on ovarian cancer...
Phase 1, Phase 2
Rochester, Minnesota, United States and 2 other locations
in combination with Pembrolizumab, or Pembrolizumab and Pegylated Liposomal Doxorubicin in patients with platinum resistant or refractory ovarian...
Phase 1, Phase 2
Rochester, Minnesota, United States and 3 other locations
The goal of this study is to test A2B694, an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorec ...
Phase 1, Phase 2
Rochester, Minnesota, United States and 10 other locations
pharmacokinetics (PK), pharmacodynamics (PDx), and anti- tumor activity of ETX-19477, a novel reversible small molecule inhibitor of PARG....
Phase 1, Phase 2
Rochester, Minnesota, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal